Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

CASI Pharmaceuticals- Inc. (CASI)

5.87 0.04 (0.69%)

06-20 11:06

Open:

5.76

Pre. Close:

5.83

High:

5.9893

Low:

5.76

Volume:

99,839

Market Cap:

506M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.167 - 6.2

6.2 - 6.227

Low:

5.518 - 5.553

5.553 - 5.582

Close:

5.772 - 5.832

5.832 - 5.883

Technical analysis  (as of: 2018-06-20 10:57:09 AM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 8.13     One year: 9.40

Support:

Support1: 5.19    Support2: 4.32

Resistance:

Resistance1: 6.96    Resistance2: 8.05

Pivot:

6.11

Moving Averages:

MA(5): 5.86     MA(20): 6.26

MA(100): 5.45     MA(250): 3.45

MACD:

MACD(12,26): -0.28     Signal(12,26,9): -0.24

%K %D:

%K(14,3): 45.11     %D(3): 41.90

RSI:

RSI(14): 41.93

52-Week:

High: 8.42  Low: 0.92  Change(%): 496.0

Average Vol(K):

3-Month: 77347  10-Days 46245

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CASI has closed above bottom band by 33.3%. Bollinger Bands are 24.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-29T07:00:00-04:00
CASI Pharmaceuticals To Present At The BIO International Convention

2018-05-15T07:00:00-04:00
CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results

2018-04-06T12:36:13-04:00
Midday Gainers / Losers (04/06/2018)

2018-04-05T08:00:00-04:00
CASI Pharmaceuticals Provides Update On EVOMELA®

2018-04-04T09:17:40-04:00
Premarket Gainers as of 9:05 am (04/04/2018)

2018-04-03T12:45:08-04:00
Midday Gainers / Losers (4/3/2018)

2018-04-03T07:00:00-04:00
CASI Pharmaceuticals To Present At The H.C. Wainwright Global Life Sciences Conference

2018-04-02T12:45:31-04:00
Midday Gainers / Losers (4/2/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

86.15

Shares Float (M)

84.06

% Held by Insiders

% Held by Institutions

4.30

Shares Short (K)

2107

Shares Short Prior Month (K)

260

Stock Financials

EPS

-0.200

EPS Est. Current Year

-0.150

EPS Est. Next Year

-0.190

EPS Est. Next Quarter

Forward EPS

-0.190

Book Value (p.s.)

7.170

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-25.0

Return on Equity (ttm)

-28.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.046

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.40

Levered Free Cash Flow (M)

-3.11

atoplab.com

Valuation

P/E

-29.50

P/E Growth Ratio

0.01

P/BV

0.82

P/S

P/CF

-79.42

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.